Filing Details

Accession Number:
0001179110-17-006134
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-04-20 20:29:17
Reporting Period:
2017-04-18
Filing Date:
2017-04-20
Accepted Time:
2017-04-20 20:29:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1641640 Nabriva Therapeutics Ag NBRV () E9
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1232258 Ltd. (Cayman) Investments Healthcare Hbm Governors Square, Suite #4-212-2
23 Lime Tree Bay Ave., West Bay
Grand Cayman E9 00000
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
American Depository Shares Representing Common Shares Disposition 2017-04-18 11,822 $11.16 2,624,633 No 4 S Direct
American Depository Shares Representing Common Shares Disposition 2017-04-19 11,785 $11.07 2,612,848 No 4 S Direct
American Depository Shares Representing Common Shares Disposition 2017-04-20 325 $11.00 2,612,523 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Each American Depository Share of the Issuer ("ADS") represents one-tenth (1/10th) of a Common Share. The Reporting Person holds both Common Shares and ADSs representing Common Shares, and Column 5 reports such holdings on an aggregate basis in terms of the corresponding number of ADSs.
  2. The price reported in Column 4 is a weighted average price. These ADSs were sold in multiple transactions ranging from $11.13 to $11.20. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price.
  3. The price reported in Column 4 is a weighted average price. These ADSs were sold in multiple transactions ranging from $11.05 to $11.20. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price.